Parkinson Disease and Complex Parkinsonism

Gene: ARSA

Amber List (moderate evidence)

ARSA (arylsulfatase A)
EnsemblGeneIds (GRCh38): ENSG00000100299
EnsemblGeneIds (GRCh37): ENSG00000100299
OMIM: 607574, Gene2Phenotype
ARSA is in 20 panels

2 reviews

Ida Ertmanska (Genomics England Curator)

I don't know

Comment on list classification: ARSA deficiency is a well-established cause of recessive metachromatic leukodystrophy. There is also some emerging evidence that heterozygous variants in ARSA may be a genetic modifier of Parkinson's disease. However, heterozygous variants act as risk factors, rather than causing familial dominant disease. Hence, the mode of inheritance should remain as 'BIALLELIC, autosomal or pseudoautosomal' on this panel.
Created: 8 Jul 2026, 9:49 a.m. | Last Modified: 8 Jul 2026, 9:49 a.m.
Panel Version: 1.128
PMID: 37381728 Senkevich et al., 2023
Authors performed burden analyses in six independent cohorts with 5801 PD patients and 20,475 controls, followed by meta-analysis, and found evidence for associations between rare functional ARSA variants and PD in four cohorts (P ≤ 0.05 in each). Of note: "results should be interpreted with caution as no association survived multiple comparisons correction."

Authors also found potential co-segregation of p.E382K variant in two unrelated PD patients with history of MLD and PD. The variant was not found in any controls.
Family A, patient II-4 - 62yo, had Parkinson's disease, het for p.E382K; also a carrier of the GBA1 variant RecNcil - hence, impossible to estimate the role of the ARSA variant in PD.
Family A, individual IV-1 - 12yo, diagnosed with MLD, comp het for ARSA variants p.E382K and c.465G>T, p.Q155H.
Caveat: variant p.E382K = c.1150G>A, p.Glu384Lys (p.E384K) - MAF = 0.00005331 in gnomAD v4.1.1., no homozygotes. P/LP classification in ClinVar.
Family B: 5 family members with Parkinson's disease, 4 deceased and not genotyped (77-82yrs), individual II-4 (72yo) had PD and was ARSA wt/wt. Individual IV-1: 7yo, MLD diagnosis, comp het for ARSA variants p.E382K and c.1107+1G>A. Other het p.E382K carriers are aged under 60yo so not known if they will be affected by PD.

PMID: 31312839 Lee et al., 2019
Reported a 32yo female proband with MLD, comp het for ARSA variants p.L300S and p.C174Y. Her father and paternal uncle had Parkinson's disease, and were heterozygous for the ARSA p.L300S variant - thought to be a potential risk factor.
Also analysed 92 cases with familial dominant Parkinson's disease. ARSA p.N352S was found to be a protective variant (more common in controls than PD cohort).
"ARSA is a genetic modifier of Parkinson's disease pathogenesis, acting as a molecular chaperone for α-synuclein." In cell lines, authors showed that ARSA deficiency correlates with an increase in α-synuclein aggregation.
Created: 7 Jul 2026, 5:15 p.m. | Last Modified: 8 Jul 2026, 9:39 a.m.
Panel Version: 1.128

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Metachromatic leukodystrophy, OMIM:250100; metachromatic leukodystrophy, MONDO:0018868; arylsulfatase A deficiency

Publications

David Collier (King's College London)

I don't know

Association bertween these gene and Parkinson's has been controversial, however a recent publication adds to the supportive evidence for this gene (PMID: 37381728). Gene for Metachromatic leukodystrophy (MIM 250100 AR)
Sources: Expert list
Created: 26 Jun 2024, 3:57 p.m.

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Publications

History Filter Activity

29 Aug 2024, Gel status: 2

Set publications

Sarah Leigh (Genomics England Curator)

Publications for gene: ARSA were set to 37381728; 31312839

29 Aug 2024, Gel status: 2

Set Phenotypes

Sarah Leigh (Genomics England Curator)

Phenotypes for gene: ARSA were changed from to Metachromatic leukodystrophy, OMIM:250100; metachromatic leukodystrophy, juvenile form, MONDO:0009591

29 Aug 2024, Gel status: 2

Entity classified by Genomics England curator

Sarah Leigh (Genomics England Curator)

Gene: arsa has been classified as Amber List (Moderate Evidence).

29 Aug 2024, Gel status: 3

Set publications

Sarah Leigh (Genomics England Curator)

Publications for gene: ARSA were set to PMID: 37381728 PMID: 31312839 PMID: 31312839

29 Aug 2024, Gel status: 3

Entity classified by Genomics England curator

Sarah Leigh (Genomics England Curator)

Gene: arsa has been classified as Green List (High Evidence).

26 Jun 2024, Gel status: 0

Created, Added New Source, Set mode of inheritance, Set publications, Set penetrance

David Collier (King's College London)

gene: ARSA was added gene: ARSA was added to Parkinson Disease and Complex Parkinsonism. Sources: Expert list Mode of inheritance for gene: ARSA was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Publications for gene: ARSA were set to PMID: 37381728 PMID: 31312839 PMID: 31312839 Penetrance for gene: ARSA were set to unknown Review for gene: ARSA was set to AMBER